BPI West
Date: March 9-11, 2026
Location: San Diego Convention Center, San Diego, California
JOIN US!
Catalent enables faster, more reliable development of next‑generation and hard‑to‑express biologics with high‑titer cell lines and integrated Gene‑to‑GMP workflows. Meet with our team at BPI West to learn how GPEx® Lightning and our end‑to‑end development capabilities help you accelerate timelines and reduce risk from early development through manufacturing.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Speaker: Nick Sanek, Group Leader, Cell Line Development, Catalent
Date/Time: Wednesday, March 11th 12:15pm during the Cell Line Development & Engineering track
Title: GPEx® Lightning: Overcoming Challenges to Deliver Difficult to Express Proteins
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
